AI Score

Unlock

AI Score

Our AI model analyzes fundamental, technical, and statistical indicators to predict the probability of a bullish trend over the next three months.

We regularly update and refine our models to deliver the most reliable forecasts for you.

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

ReShape Lifesciences Inc. (RSLS)

AI Score

Unlock

AI Score

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

1.24

-0.12 (-8.82%)

At close: Feb 20, 2025, 3:59 PM

1.19

-3.96%

After-hours: Feb 20, 2025, 06:37 PM EST

undefined% (undefined)

Bid	1.19
Market Cap	904.52K
Revenue (ttm)	-
Net Income (ttm)	-
EPS (ttm)	77.26
PE Ratio (ttm)	0.02
Forward PE	n/a
Analyst	Hold

Ask	1.2
Volume	3,099,098
Avg. Volume (20D)	797,589
Open	1.29
Previous Close	1.36
Day's Range	1.18 - 1.36
52-Week Range	1.01 - 29.00
Beta	undefined

About RSLS

ReShape Lifesciences Inc., a medical device company, provides products and services that manages and treat obesity and metabolic diseases in the United States, Australia, Europe, and internationally. The company's product portfolio includes Lap-Band System, a minimally invasive long-term treatment of severe obesity and more invasive surgical stapling procedures, such as the gastric bypass or sleeve gastrectomy; and ReShape Vest system, an investi...

[Show more]

Industry Medical - Devices

Sector Healthcare

IPO Date Oct 6, 2016

Employees 29

Stock Exchange NASDAQ

Ticker Symbol RSLS

Website https://www.reshapelifesciences.com

Full Company Profile

Analyst Forecast

According to 1 analyst ratings, the average rating for RSLS stock is "Hold." The 12-month stock price forecast is $undefined, which is a decrease of NaN% from the latest price.

Buy 0.00%

Hold 100.00%

Sell 0.00%

Stock Forecasts

Why Price Moved

3 days ago

-53.65%

ReShape Lifesciences shares are trading lower afte... Unlock content with Pro Subscription

3 months ago

-8.01%

ReShape Lifesciences shares are trading lower. The company reported Q3 financial results.

News

3 months ago · seekingalpha.com

ReShape Lifesciences Inc. (RSLS) Q3 2024 Earnings Call Transcript

ReShape Lifesciences Inc. (NASDAQ:RSLS ) Q3 2024 Earnings Conference Call November 14, 2024 4:30 PM ET Company Participants Michael Miller - Rx Communications Paul Hickey - President and CEO Thomas St...